Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jorge Joven

Showing results (1-10 of 299) with videos related to

Pageof 30
Sort By:
The New England Journal of Medicine|January 14, 2005
Hookworm infectionJorge Joven
Clinical Chemistry and Laboratory Medicine|November 7, 2016
Metabolite profiling can change health-care delivery to obese patients with fatty liver disease: the search for biomarkersJordi Camps, Jorge Joven
World Journal of Gastroenterology|March 18, 2015
Chemokine ligand 2 and paraoxonase-1 in non-alcoholic fatty liver disease: The search for alternative causative factorsJordi Camps, Jorge Joven
Medicina Clinica|August 30, 2002
[Clinical applications of erythropoietin: Impact on blood transfusion]Teresa Sans, Jorge Joven
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|September 3, 2025
Jorge Joven, Jordi Camps
Aging|March 26, 2013
One-carbon metabolism: an aging-cancer crossroad for the gerosuppressant metforminJavier A Menendez, Jorge Joven
Advances in Experimental Medicine and Biology|July 21, 2014
Energy metabolism and metabolic sensors in stem cells: the metabostem crossroads of aging and cancerJavier A Menendez, Jorge Joven
Medicina Clinica|March 20, 2012
[Human immunodeficiency virus infection as a model of premature aging: perspectives and implications]Jorge Joven, Javier A Menendez
Clinica Chimica Acta; International Journal of Clinical Chemistry|September 14, 2007
Measurement of serum paraoxonase-1 activity as a potential biomarker for chronic liver impairmentJordi Camps, Judit Marsillach, Jorge Joven
Critical Reviews in Clinical Laboratory Sciences|March 4, 2009
The paraoxonases: role in human diseases and methodological difficulties in measurementJordi Camps, Judit Marsillach, Jorge Joven
Pageof 30

Showing results (1-10 of 299) with videos related to

Sort By:
Pageof 30
The New England Journal of Medicine|January 14, 2005
Hookworm infectionJorge Joven
Clinical Chemistry and Laboratory Medicine|November 7, 2016
Metabolite profiling can change health-care delivery to obese patients with fatty liver disease: the search for biomarkersJordi Camps, Jorge Joven
World Journal of Gastroenterology|March 18, 2015
Chemokine ligand 2 and paraoxonase-1 in non-alcoholic fatty liver disease: The search for alternative causative factorsJordi Camps, Jorge Joven
Medicina Clinica|August 30, 2002
[Clinical applications of erythropoietin: Impact on blood transfusion]Teresa Sans, Jorge Joven
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|September 3, 2025
Jorge Joven, Jordi Camps
Aging|March 26, 2013
One-carbon metabolism: an aging-cancer crossroad for the gerosuppressant metforminJavier A Menendez, Jorge Joven
Advances in Experimental Medicine and Biology|July 21, 2014
Energy metabolism and metabolic sensors in stem cells: the metabostem crossroads of aging and cancerJavier A Menendez, Jorge Joven
Medicina Clinica|March 20, 2012
[Human immunodeficiency virus infection as a model of premature aging: perspectives and implications]Jorge Joven, Javier A Menendez
Clinica Chimica Acta; International Journal of Clinical Chemistry|September 14, 2007
Measurement of serum paraoxonase-1 activity as a potential biomarker for chronic liver impairmentJordi Camps, Judit Marsillach, Jorge Joven
Critical Reviews in Clinical Laboratory Sciences|March 4, 2009
The paraoxonases: role in human diseases and methodological difficulties in measurementJordi Camps, Judit Marsillach, Jorge Joven
Pageof 30